Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 9/20 | 0.97 |
| ▸ | KMT2A | Q03164 | 9/20 | 0.97 |
| ▸ | CYP1A2 | P05177 | 8/20 | 0.97 |
| ▸ | CYP1A1 | P04798 | 7/20 | 0.97 |
| ▸ | CYP1B1 | Q16678 | 7/20 | 0.97 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.97 |
| ▸ | HSD17B10 | Q99714 | 6/20 | 0.97 |
| ▸ | CYP3A4 | P08684 | 6/20 | 0.97 |
| ▸ | MAPT | P10636 | 6/20 | 0.97 |
| ▸ | POLH | Q9Y253 | 6/20 | 0.97 |
| ▸ | ABCB1 | P08183 | 6/20 | 0.97 |
| ▸ | CYP2C9 | P11712 | 5/20 | 0.97 |
| ▸ | RECQL | P46063 | 5/20 | 0.97 |
| ▸ | IPMK | Q8NFU5 | 5/20 | 0.97 |
| ▸ | IP6K2 | Q9UHH9 | 5/20 | 0.97 |
| ▸ | XDH | P47989 | 5/20 | 0.97 |
| ▸ | FTO | Q9C0B1 | 5/20 | 0.97 |
| ▸ | ALOX15 | P16050 | 4/20 | 0.97 |
| ▸ | HIF1A | Q16665 | 4/20 | 0.97 |
| ▸ | POLB | P06746 | 4/20 | 0.97 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Quercetin SCHEMBL31507620 | 0.99 | MEN1 (1.00) | MEN1KMT2ACYP1A2CYP1A1CYP1B1 | |
| Quercetin SCHEMBL118425 | 0.99 | MEN1 (1.00) | MEN1KMT2ACYP1A2CYP1A1CYP1B1 | |
| Quercetin SCHEMBL29723041 | 0.99 | MEN1 (1.00) | MEN1KMT2ACYP1A2CYP1A1CYP1B1 | |
| Quercetin SCHEMBL19723 | 0.99 | MEN1 (1.00) | MEN1KMT2ACYP1A2CYP1A1CYP1B1 | |
| Quercetin SCHEMBL17629824 | 0.99 | MEN1 (1.00) | MEN1KMT2ACYP1A2CYP1A1CYP1B1 | |
| Quercetin SCHEMBL29351036 | 0.99 | MEN1 (1.00) | MEN1KMT2ACYP1A2CYP1A1CYP1B1 | |
| Quercetin SCHEMBL29353785 | 0.99 | MEN1 (1.00) | MEN1KMT2ACYP1A2CYP1A1CYP1B1 | |
| Quercetin SCHEMBL3786991 | 0.97 | MEN1 (0.97) | MEN1KMT2ACYP1A2CYP1A1CYP1B1 | |
| Quercetin SCHEMBL6756842 | 0.97 | MEN1 (0.97) | MEN1KMT2ACYP1A2CYP1A1CYP1B1 | |
| Quercetin SCHEMBL22103 | 0.97 | MEN1 (1.00) | MEN1KMT2ACYP1A2CYP1A1CYP1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110407895-B | Method for extracting and separating quercetin from polygonum cuspidatum leaves | 重庆市中药研究院 | 2022-11-29 | — | — | CN | claimed |
| EP-2665467-A2 | FLAVONOL COMPOSITIONS | Ono, Mitsunori (US) | 2013-11-27 | — | — | EP | claimed |
| WO-2012099930-A2 | FLAVONOL COMPOSITIONS | ONO MITSUNORI (US) | 2012-07-26 | — | — | WO | claimed |
| US-20120183587-A1 | FLAVONOL COMPOSITIONS | LINES, THOMAS CHRISTIAN (CH) | 2012-07-19 | — | — | US | claimed |
| US-7399475-B1 | Inactivated microorganisms comprising substances having pharmacological activity | TONER ENTERPRISE INC. (LI) | 2008-07-15 | — | — | US | claimed |
| EP-1171103-B1 | INACTIVATED MICROORGANISMS COMPRISING SUBSTANCES HAVING PHARMACOLOGICAL ACTIVITY | TONER ENTPR INC (LI) | 2004-12-29 | — | — | EP | claimed |
| US-4755504-A | Pharmaceutical composition from Tienchi | LIU YAGUANG (US) | 1988-07-05 | — | — | US | claimed |
| WO-2025038371-A1 | SALT-LOADED SOLID LIPID NANOPARTICLES LOADED WITH AN ACTIVE AGENT | PURDUE RESEARCH FOUNDATION (US) | 2025-02-20 | — | — | WO | disclosed |
| CN-110407895-B | Method for extracting and separating quercetin from polygonum cuspidatum leaves | 重庆市中药研究院 | 2022-11-29 | — | — | CN | disclosed |
| US-7399475-B1 | Inactivated microorganisms comprising substances having pharmacological activity | TONER ENTERPRISE INC. (LI) | 2008-07-15 | — | — | US | disclosed |
| US-20060062822-A1 | Medical devices to treat or inhibit restenosis | MEDTRONIC VASCULAR, INC. (US) | 2006-03-23 | — | — | US | disclosed |
| EP-1171103-B1 | INACTIVATED MICROORGANISMS COMPRISING SUBSTANCES HAVING PHARMACOLOGICAL ACTIVITY | TONER ENTPR INC (LI) | 2004-12-29 | — | — | EP | disclosed |
| EP-1171103-A2 | INACTIVATED MICROORGANISMS COMPRISING SUBSTANCES HAVING PHARMACOLOGICAL ACTIVITY | Toner Enterprise Inc. (LI) | 2002-01-16 | — | — | EP | disclosed |
| WO-2000064417-A2 | INACTIVATED MICROORGANISMS COMPRISING SUBSTANCES HAVING PHARMACOLOGICAL ACTIVITY | TONER ENTERPRISE INC. (LI) | 2000-11-02 | — | — | WO | disclosed |
| WO-1996016667-A1 | COSMETIC COMPOSITIONS COMPRISING PILOCARPUS JABORANDI, ALOE VERA EXTRACTS | PVP SOCIEDADE ANÔNIMA (BR) | 1996-06-06 | — | — | WO | disclosed |
| US-4755504-A | Pharmaceutical composition from Tienchi | LIU YAGUANG (US) | 1988-07-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060062822-A1 | Medical devices to treat or inhibit restenosis | ALDOA, AKR1B1, AKR1C2 | MEN1 2391/4885KMT2A 3025/4885CYP1A2 870/4885 |
| US-20120183587-A1 | FLAVONOL COMPOSITIONS | CYP2F1, F3, TEAD3 | MEN1 2383/4885KMT2A 2991/4885CYP1A2 167/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.